MedTrace Logo

Inflammation and Steatosis: the Role of Alpha-defensin

NCT03358420 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2017-11-30

No results posted yet for this study

Summary

The aim of this study is to examine the correlation between the severity of non-alcoholic steatohepatitis/non alcoholic fatty liver disease (NASH/NAFLD) in naïve and hepatitis C (HCV) positive patients and the amplitude of alpha-defensin immunohistochemical staining in liver biopsy.

Conditions

Interventions

DIAGNOSTIC_TEST

Immunohistochemical staining

Pathological liver slides to be immunohistochemically stained for alpha-defensin

Sponsors & Collaborators

  • Hillel Yaffe Medical Center

    lead OTHER_GOV

Principal Investigators

  • Rami Abu Fanne, MD · Hillel Yaffe Medical Center

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-31
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03358420 on ClinicalTrials.gov